Showing results (121-130 of 162) with videos related to
Sort By:
Pageof 17
European Journal of Pharmacology|December 2, 2010
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat loadGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.Diabetes/Metabolism Research and Reviews|October 24, 2019
Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study)Giuseppe Derosa, Gabriele Catena, Laura Scelsi, et al.Metabolism: Clinical and Experimental|October 23, 2008
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazoneGiuseppe Derosa, Angela D'Angelo, Sibilla A T Salvadeo, et al.British Journal of Clinical Pharmacology|December 2, 2015
Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Claudio Pedone, et al.Drug Design, Development and Therapy|June 6, 2017
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled studySergio D'Addato, Luciana Scandiani, Giuliana Mombelli, et al.Diabetes Technology & Therapeutics|April 20, 2012
Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.Canadian Journal of Physiology and Pharmacology|August 30, 2013
Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapyGiuseppe Derosa, Arrigo F G Cicero, Ivano G Franzetti, et al.Current Medical Research and Opinion|June 27, 2009
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Metabolism: Clinical and Experimental|April 28, 2009
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's studyGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Current Medical Research and Opinion|February 24, 2009
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trialGiuseppe Derosa, Sibilla A T Salvadeo, Angela D'Angelo, et al.Pageof 17